Comparing the results of human chorionic gonadotropin and dual triggering protocols in consecutive IVF cycles of women with poor ovarian response: A retrospective case-control study.
Authors:
- Melis Gokce Kocer YaziciMYMelis Gokce Kocer Yazici
- Gulcin OzkaraGOGulcin Ozkara
- Mert YesiladaliMYMert Yesiladali
- Ece Gumusoglu CaglarECEce Gumusoglu Caglar
Preprint
- 4 October 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose Bolus administration of GnRH analogs mimics physiological ovulation and adding GnRH-a to hCG (“dual triggering”) to induce final oocyte maturation stimulates the luteinizing hormone surge which improves IVF outcomes by decreasing immature oocyte rates. Effects of dual triggering on oocytes have been investigated in previous studies. However, retrieved oocytes in consecutive hCG and dual triggering cycles of poor responder(POR) patients has not been studied yet. In this study, we aimed to examine the retrieved/mature oocyte counts after administering hCG and dual triggering to POR patients in their consecutive IVF cycles. Method A total of 54 patients with two consecutive cycles within two years were included into this single-centered, retrospective cohort study that was conducted at Yeditepe University Hospitals, Istanbul, Turkey, between 2014 and 2021. All patients were diagnosed with POR according to the Bologna Criteria (2011). Dual vs hCG triggering protocols were compared using Wilcoxon test in terms of oocyte count and maturation. Results Although a statistically significant difference was observed between the ages of patients in their consecutive IVF cycles, it did not have a clinical significance (38.80±3.72 vs 38.17±3.75, p0.05). No statistically significant difference was found in terms of total and mature oocytes between two protocols. Conclusion The results demonstrated that the choice of triggering method, whether hCG or dual triggering, did not significantly influence neither the retrieved oocyte count nor maturation in POR patients.Keywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cyclesFertility and Sterility, 2013
- GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patientsHuman Reproduction, 2013
- Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high respondersFertility and Sterility, 2012
- ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteriaHuman Reproduction, 2011
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles2011
- Ovarian hyperstimulation syndromeFertility and Sterility, 2008
- Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized studyFertility and Sterility, 2008
- Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cyclesFertility and Sterility, 2007
- GnRH antagonists in IVFReproductive BioMedicine Online, 2005
- GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized studyHuman Reproduction, 2005